Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 237838011000036115 | Fabrazyme (agalsidase beta 5 mg) powder for injection, 1 x 5 mg vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 237839011000036111 | Fabrazyme 5 mg powder for injection, 1 vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fabrazyme 5 mg powder for injection, 1 vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Fabrazyme 5 mg powder for injection, 1 vial | Is a | agalsidase beta 5 mg injection, 1 vial | true | Inferred relationship | Some | ||
| Fabrazyme 5 mg powder for injection, 1 vial | has TPUU | Fabrazyme 5 mg powder for injection, 5 mg vial | true | Inferred relationship | Some | 1 | |
| Fabrazyme 5 mg powder for injection, 1 vial | has TP | Fabrazyme | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fabrazyme 5 mg powder for injection, 1 vial | Is a | True | Fabrazyme 5 mg powder for injection, 1 vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR